The Board of Shukra Pharmaceuticals at its meeting held on 11 May 2020 has approved the appointment of Mehul Patel as Chief Financial Officer [KMPJ of the Company. The Board has also appointed Ashvin Trivedi [DIN: 032L2457) as an additional Non-executive director of the Company. Further, the Board has accepted and taken note of Resignation of Karnik Shah as Chief Executive Officer [CEO) of the Company,
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
